Burning Operating Cash Flow Per Share vs Capex To Revenue Analysis

BNR Stock

USD 6.78 0.11 1.65%

Burning Rock financial indicator trend analysis is way more than just evaluating Burning Rock Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Burning Rock Biotech is a good investment. Please check the relationship between Burning Rock Operating Cash Flow Per Share and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Operating Cash Flow Per Share vs Capex To Revenue

Operating Cash Flow Per Share vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Burning Rock Biotech Operating Cash Flow Per Share account and Capex To Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between Burning Rock's Operating Cash Flow Per Share and Capex To Revenue is 0.73. Overlapping area represents the amount of variation of Operating Cash Flow Per Share that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Burning Rock Biotech, assuming nothing else is changed. The correlation between historical values of Burning Rock's Operating Cash Flow Per Share and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Cash Flow Per Share of Burning Rock Biotech are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Operating Cash Flow Per Share i.e., Burning Rock's Operating Cash Flow Per Share and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.73

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Burning Rock's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Burning Rock Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of 01/30/2025, Tax Provision is likely to grow to about 3.9 M, while Selling General Administrative is likely to drop slightly above 327.9 M.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	124.1M	133.4M	153.4M	161.1M
Interest Income	9.5M	15.3M	17.5M	10.0M

Depreciation And Amortization Interest Income

Burning Rock fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations
Common Stock Shares Outstanding		-0.07	0.42	-0.09	0.14	-0.18	0.01	-0.25	0.08	-0.32	0.08	0.54	0.2	-0.11	0.1	0.17	-0.2	0.31	-0.08	-0.3	-0.45	0.19	0.31	0.39	-0.28	0.34
Total Assets	-0.07		-0.79	0.77	0.27	0.96	0.5	0.93	0.73	0.65	-0.98	-0.6	0.82	0.99	0.75	0.86	0.84	-0.83	0.99	0.57	0.84	0.45	-0.83	-0.67	0.79	0.55
Short Long Term Debt Total	0.42	-0.79		-0.82	-0.1	-0.77	-0.41	-0.8	-0.63	-0.79	0.77	0.88	-0.54	-0.73	-0.65	-0.59	-0.81	0.99	-0.73	-0.91	-0.9	-0.29	0.99	0.58	-0.96	-0.36
Other Current Liab	-0.09	0.77	-0.82		0.61	0.79	0.63	0.8	0.89	0.91	-0.76	-0.84	0.84	0.73	0.88	0.79	0.86	-0.84	0.67	0.75	0.87	-0.02	-0.84	-0.7	0.82	0.72
Total Current Liabilities	0.14	0.27	-0.1	0.61		0.4	0.63	0.38	0.7	0.61	-0.27	-0.4	0.71	0.31	0.63	0.55	0.49	-0.12	0.18	0.04	0.42	-0.63	-0.12	-0.64	0.1	0.7
Total Stockholder Equity	-0.18	0.96	-0.77	0.79	0.4		0.53	0.99	0.73	0.74	-0.98	-0.69	0.8	0.98	0.72	0.81	0.87	-0.78	0.95	0.5	0.9	0.26	-0.78	-0.84	0.76	0.54
Other Liab	0.01	0.5	-0.41	0.63	0.63	0.53		0.54	0.89	0.73	-0.47	-0.53	0.76	0.48	0.87	0.8	0.83	-0.46	0.39	0.45	0.56	-0.31	-0.46	-0.52	0.46	0.89
Net Tangible Assets	-0.25	0.93	-0.8	0.8	0.38	0.99	0.54		0.71	0.79	-0.96	-0.74	0.75	0.96	0.7	0.76	0.89	-0.8	0.92	0.54	0.92	0.22	-0.8	-0.86	0.8	0.51
Property Plant And Equipment Net	0.08	0.73	-0.63	0.89	0.7	0.73	0.89	0.71		0.84	-0.69	-0.67	0.94	0.68	0.99	0.93	0.91	-0.69	0.61	0.61	0.74	-0.11	-0.69	-0.62	0.66	0.94
Current Deferred Revenue	-0.32	0.65	-0.79	0.91	0.61	0.74	0.73	0.79	0.84		-0.66	-0.93	0.7	0.63	0.81	0.67	0.9	-0.78	0.54	0.73	0.89	-0.25	-0.78	-0.79	0.8	0.66
Net Debt	0.08	-0.98	0.77	-0.76	-0.27	-0.98	-0.47	-0.96	-0.69	-0.66		0.6	-0.78	-0.99	-0.71	-0.81	-0.83	0.8	-0.98	-0.52	-0.83	-0.43	0.8	0.72	-0.79	-0.53
Retained Earnings	0.54	-0.6	0.88	-0.84	-0.4	-0.69	-0.53	-0.74	-0.67	-0.93	0.6		-0.52	-0.58	-0.65	-0.5	-0.8	0.83	-0.51	-0.78	-0.92	0.18	0.83	0.76	-0.81	-0.4
Accounts Payable	0.2	0.82	-0.54	0.84	0.71	0.8	0.76	0.75	0.94	0.7	-0.78	-0.52		0.8	0.94	0.97	0.83	-0.61	0.74	0.42	0.69	0.02	-0.61	-0.65	0.55	0.88
Cash	-0.11	0.99	-0.73	0.73	0.31	0.98	0.48	0.96	0.68	0.63	-0.99	-0.58	0.8		0.69	0.82	0.82	-0.76	0.99	0.46	0.84	0.39	-0.76	-0.75	0.73	0.51
Non Current Assets Total	0.1	0.75	-0.65	0.88	0.63	0.72	0.87	0.7	0.99	0.81	-0.71	-0.65	0.94	0.69		0.95	0.9	-0.72	0.64	0.65	0.73	-0.03	-0.72	-0.57	0.68	0.93
Non Currrent Assets Other	0.17	0.86	-0.59	0.79	0.55	0.81	0.8	0.76	0.93	0.67	-0.81	-0.5	0.97	0.82	0.95		0.87	-0.67	0.79	0.5	0.69	0.16	-0.67	-0.57	0.62	0.88
Other Assets	-0.2	0.84	-0.81	0.86	0.49	0.87	0.83	0.89	0.91	0.9	-0.83	-0.8	0.83	0.82	0.9	0.87		-0.83	0.76	0.71	0.89	0.03	-0.83	-0.75	0.83	0.76
Long Term Debt	0.31	-0.83	0.99	-0.84	-0.12	-0.78	-0.46	-0.8	-0.69	-0.78	0.8	0.83	-0.61	-0.76	-0.72	-0.67	-0.83		-0.77	-0.92	-0.88	-0.35	1.0	0.53	-0.97	-0.45
Cash And Short Term Investments	-0.08	0.99	-0.73	0.67	0.18	0.95	0.39	0.92	0.61	0.54	-0.98	-0.51	0.74	0.99	0.64	0.79	0.76	-0.77		0.46	0.79	0.52	-0.77	-0.65	0.73	0.44
Net Receivables	-0.3	0.57	-0.91	0.75	0.04	0.5	0.45	0.54	0.61	0.73	-0.52	-0.78	0.42	0.46	0.65	0.5	0.71	-0.92	0.46		0.71	0.22	-0.92	-0.28	0.91	0.42
Common Stock Total Equity	-0.45	0.84	-0.9	0.87	0.42	0.9	0.56	0.92	0.74	0.89	-0.83	-0.92	0.69	0.84	0.73	0.69	0.89	-0.88	0.79	0.71		0.03	-0.88	-0.86	0.84	0.47
Short Term Investments	0.19	0.45	-0.29	-0.02	-0.63	0.26	-0.31	0.22	-0.11	-0.25	-0.43	0.18	0.02	0.39	-0.03	0.16	0.03	-0.35	0.52	0.22	0.03		-0.35	0.26	0.35	-0.14
Long Term Debt Total	0.31	-0.83	0.99	-0.84	-0.12	-0.78	-0.46	-0.8	-0.69	-0.78	0.8	0.83	-0.61	-0.76	-0.72	-0.67	-0.83	1.0	-0.77	-0.92	-0.88	-0.35		0.53	-0.97	-0.45
Non Current Liabilities Total	0.39	-0.67	0.58	-0.7	-0.64	-0.84	-0.52	-0.86	-0.62	-0.79	0.72	0.76	-0.65	-0.75	-0.57	-0.57	-0.75	0.53	-0.65	-0.28	-0.86	0.26	0.53		-0.51	-0.41
Capital Surpluse	-0.28	0.79	-0.96	0.82	0.1	0.76	0.46	0.8	0.66	0.8	-0.79	-0.81	0.55	0.73	0.68	0.62	0.83	-0.97	0.73	0.91	0.84	0.35	-0.97	-0.51		0.45
Capital Lease Obligations	0.34	0.55	-0.36	0.72	0.7	0.54	0.89	0.51	0.94	0.66	-0.53	-0.4	0.88	0.51	0.93	0.88	0.76	-0.45	0.44	0.42	0.47	-0.14	-0.45	-0.41	0.45

Click cells to compare fundamentals

Burning Rock Account Relationship Matchups

Burning Rock fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	68.6M	104.2M	103.9M	10.2M	9.2M	8.8M
Total Assets	2.7B	2.3B	1.6B	1.0B	1.2B	1.6B
Short Long Term Debt Total	46.9M	86.7M	50.8M	12.3M	11.1M	10.5M
Other Current Liab	76.7M	120.2M	162.8M	84.3M	97.0M	97.1M
Total Current Liabilities	241.5M	372.2M	411.5M	263.4M	302.9M	318.6M
Total Stockholder Equity	2.4B	1.8B	1.2B	768.4M	883.7M	861.3M
Other Liab	991K	491K	11.8M	4.1M	4.7M	4.3M
Net Tangible Assets	(891.8M)	2.4B	1.8B	1.2B	1.3B	862.0M
Property Plant And Equipment Net	111.5M	406.4M	300.0M	144.2M	165.8M	205.5M
Current Deferred Revenue	75.5M	143.8M	149.4M	131.7M	151.5M	112.2M
Net Debt	(1.8B)	(1.3B)	(854.7M)	(602.8M)	(542.5M)	(569.6M)
Retained Earnings	(1.4B)	(2.2B)	(3.2B)	(3.9B)	(3.5B)	(3.3B)
Accounts Payable	35.5M	63.1M	50.9M	18.1M	20.8M	36.0M
Cash	1.9B	1.4B	905.5M	615.1M	707.4M	923.0M
Non Current Assets Total	139.4M	457.6M	328.7M	155.9M	179.3M	238.7M
Non Currrent Assets Other	23.0M	45.1M	26.0M	10.4M	12.0M	22.6M
Other Assets	11.0M	23.0M	45.1M	26.0M	29.9M	24.8M
Cash And Short Term Investments	2.3B	1.5B	905.5M	615.1M	707.4M	1.1B
Net Receivables	110.8M	161.4M	170.2M	167.8M	193.0M	165.2M
Short Term Investments	362.1M	63.8M	2.1M	13.4M	12.1M	11.5M
Liabilities And Stockholders Equity	2.7B	2.3B	1.6B	1.0B	1.2B	1.6B
Non Current Liabilities Total	491K	61.1M	17.7M	8.2M	7.4M	7.0M
Capital Lease Obligations	4.8M	84.3M	50.8M	12.3M	14.2M	13.5M
Inventory	68.0M	123.2M	130.3M	69.0M	79.4M	91.3M
Other Current Assets	51.1M	41.2M	52.8M	32.2M	37.0M	33.0M
Other Stockholder Equity	4.0B	4.3B	4.5B	4.8B	5.5B	3.0B
Total Liab	242.0M	433.3M	429.1M	271.6M	244.4M	232.2M
Net Invested Capital	2.5B	1.8B	1.2B	768.4M	883.7M	928.4M
Long Term Investments	1.4M	910K	690K	337K	303.3K	288.1K
Property Plant And Equipment Gross	111.5M	406.4M	300.0M	548.3M	630.5M	662.1M
Total Current Assets	2.5B	1.8B	1.3B	884.1M	1.0B	1.4B
Accumulated Other Comprehensive Income	(167.6M)	(207.1M)	(165.7M)	(161.5M)	(145.4M)	(152.6M)
Net Working Capital	2.3B	1.4B	847.3M	620.7M	713.8M	1.1B
Short Term Debt	46.9M	37.4M	37.2M	8.6M	7.8M	7.4M
Intangible Assets	3.5M	5.2M	161K	964K	1.1M	1.9M
Property Plant Equipment	89.3M	111.5M	406.4M	300.0M	345.0M	214.9M

Pair Trading with Burning Rock

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burning Rock position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will appreciate offsetting losses from the drop in the long position's value.

Moving against Burning Stock

0.89	PDSB	PDS Biotechnology Corp	Pair Corr
0.86	JNJ	Johnson Johnson	Pair Corr
0.85	NKTX	Nkarta Inc	Pair Corr
0.78	INZY	Inozyme Pharma	Pair Corr
0.69	MREO	Mereo BioPharma Group	Pair Corr

The ability to find closely correlated positions to Burning Rock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burning Rock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burning Rock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burning Rock Biotech to buy it.

The correlation of Burning Rock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burning Rock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burning Rock Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Burning Rock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC